MYXOFIBROSARCOMA

MYXOFIBROSARCOMA was reported 54 times

MYXOFIBROSARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Leukotriene Receptor Antagonist [EPC] 2 0.0001
1 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2 0.0001
2 Antimetabolite Immunosuppressant [EPC] 1 0.0000
3 Parathyroid Hormone-Related Peptide Analog [EPC] 1 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 10 0.0000
5 Interleukin-6 Receptor Antagonist [EPC] 3 0.0000
6 Purine Antimetabolite [EPC] 2 0.0000
7 Alkylating Drug [EPC] 4 0.0000
8 Vitamin D [EPC] 4 0.0000
9 Vitamin B12 [EPC] 4 0.0000
10 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
11 Proton Pump Inhibitor [EPC] 7 0.0000
12 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
13 Platinum-based Drug [EPC] 3 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
15 RANK Ligand Inhibitor [EPC] 2 0.0000
16 5-alpha Reductase Inhibitor [EPC] 1 0.0000
17 Vitamin C [EPC] 4 0.0000
18 Parathyroid Hormone Analog [EPC] 1 0.0000
19 Proteasome Inhibitor [EPC] 1 0.0000
20 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
21 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
22 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
23 Corticosteroid [EPC] 9 0.0000
24 Aldosterone Antagonist [EPC] 1 0.0000
25 Azole Antifungal [EPC] 1 0.0000
26 Interferon beta [EPC] 1 0.0000
27 Expectorant [EPC] 1 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
29 Mood Stabilizer [EPC] 1 0.0000
30 Kinase Inhibitor [EPC] 2 0.0000
31 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
32 GLP-1 Receptor Agonist [EPC] 1 0.0000
33 Atypical Antipsychotic [EPC] 1 0.0000
34 Loop Diuretic [EPC] 1 0.0000
35 Platelet Aggregation Inhibitor [EPC] 1 0.0000